Adempas (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Adempas drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Guanylate Cyclase Stimulators [MoA],Soluble Guanylate Cyclase Stimulator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | riociguat |
| SUBSTANCE NAME: | RIOCIGUAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Guanylate Cyclase Stimulators [MoA],Soluble Guanylate Cyclase Stimulator [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-10-08 |
| END MARKETING DATE: | 0000-00-00 |
Adempas HUMAN PRESCRIPTION DRUG Details:
| Item Description | Adempas from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2013-10-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-250_55cfe406-6338-4ae0-8313-88a1466ef7d9 |
| PRODUCT NDC: | 50419-250 |
| APPLICATION NUMBER: | NDA204819 |
Other RIOCIGUAT Pharmaceutical Manufacturers / Labelers:
